Bicara Sets a Multi-Role Leadership Succession
Bicara Therapeutics announced a planned CEO succession and four additional senior-role changes around the pivotal development of ficerafusp alfa. President and COO Ryan Cohlhepp will become president and CEO on January 1, 2027; CEO…
